Rchr
J-GLOBAL ID：201901018576224461
Update date: Sep. 01, 2024
Keigo Araki
アラキ ケイゴ | Keigo Araki
Affiliation and department：
Other affiliations (1)：
Research field (1)：
Molecular biology
Research theme for competitive and other funds (3)：
- 2022 - 2025 「匂いシグナル」で制御される口腔がん細胞の細胞融合誘導機構の解析
- 2017 - 2021 Development of new therapies for malignant cancers through disruption of quality control machinery of mitochondria
- 2015 - 2017 Inhibition of G-quadruplex formation of E2F3 mRNA enhances its expression in cancer cells
Papers (23)：
-
Keigo Araki, Takeru Torii, Kohei Takeuchi, Natsuki Kinoshita, Ryoto Urano, Rinka Nakajima, Yaxuan Zhou, Tokuo Kobayashi, Tadayoshi Hanyu, Kiyoshi Ohtani, et al. Non-canonical olfactory pathway activation induces cell fusion of cervical cancer cells. Neoplasia. 2024. 57. 101044
-
Mashiro Shirasawa, Rinka Nakajima, Yaxuan Zhou, Lin Zhao, Mariana Fikriyanti, Ritsuko Iwanaga, Andrew P. Bradford, Kenta Kurayoshi, Keigo Araki, Kiyoshi Ohtani. Activation of the CDK7 Gene, Coding for the Catalytic Subunit of the Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) and General Transcription Factor II H, by the Trans-Activator Protein Tax of Human T-Cell Leukemia Virus Type-1. Genes. 2024. 15. 8. 1080-1080
-
Rahma F Hayati, Rinka Nakajima, Yaxuan Zhou, Mashiro Shirasawa, Lin Zhao, Mariana Fikriyanti, Ritsuko Iwanaga, Andrew P Bradford, Kenta Kurayoshi, Keigo Araki, et al. Trans-Activation of the Coactivator-Associated Arginine Methyltransferase 1 (Carm1) Gene by the Oncogene Product Tax of Human T-Cell Leukemia Virus Type 1. Genes. 2024. 15. 6
-
Yaxuan Zhou, Rinka Nakajima, Mashiro Shirasawa, Mariana Fikriyanti, Lin Zhao, Ritsuko Iwanaga, Andrew P Bradford, Kenta Kurayoshi, Keigo Araki, Kiyoshi Ohtani. Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression. Biology. 2023. 12. 12
-
Rinka Nakajima, Reika Deguchi, Hideyuki Komori, Lin Zhao, Yaxuan Zhou, Mashiro Shirasawa, Arlene Angelina, Yasuko Goto, Fumiya Tohjo, Kengo Nakahashi, et al. The TFDP1 gene coding for DP1, the heterodimeric partner of the transcription factor E2F, is a target of deregulated E2F. Biochemical and Biophysical Research Communications. 2023. 663. 154-162
ｍore...
MISC (2)：
Books (2)：
-
Distinct E2F-Mediated Transcriptional Mechanisms in Cell Proliferation, Endoreplication and Apoptosis
InTech Open Access Publisher 2018
-
The Key Role of E2F in Tumor Suppression through Specific Regulation of Tumor Suppressor Genes in Response to Oncogenic Changes
InTech Open Access Publisher 2018
Lectures and oral presentations (1)：
-
Analysis of cell-cell fusion mechanism in cervical cancers
(2023)
Education (2)：
- 1999 - 2003 Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences
- 1993 - 1999 Tokyo Medical and Dental University Faculty of Dentistry School of Dentistry
Professional career (1)：
Work history (5)：
- 2020/04 - 現在 Ohu University Faculty of Dentistry
- 2015/04 - 2019/03 Kwansei Gakuin University School of Science and Technology Department of Biomedical Chemistry
- 2013/07 - 2014/03 シンガポール大学 メカノバイオロジー研究所
- 2008/08 - 2013/06 シンガポール大学 がん研究所
- 2005/04 - 2007/09 Nippon Medical School
Association Membership(s) (2)：
Return to Previous Page
